From product launches to research initiatives, here are six key updates since Jan. 1 to know in the regenerative medicine industry:
Biologics
A Rhode Island man designed a first-of-its-kind spinal implant made from human bone tissue, NBC affiliate WJAR reported Feb. 23.
Orthofix's Opus BA bioactive strip was fully launched for cervical and lumbar spinal fusion, the devicemaker said Feb. 22.
Theradaptive's OsteoAdapt SP spinal implant received FDA breakthrough designation for posterolateral spinal fusion.
Ortho Regenerative Technologies has initiated a $3 million non-brokered private placement deal, the orthopedic biotechnology company said Feb. 11.
Advertisement
The global orthobiologics market is expected to grow to nearly $8 billion by 2016, according to projections from Transparency Market Research.
Sean McMillan, DO, became the first surgeon to use the Bear anterior cruciate ligament implant in New Jersey, ROI-NJ reported Feb. 3.
The California Institute of Regenerative Medicine has provided a $1.3 million grant to Kevin Stone, MD, chair of the Stone Research Foundation, and Mani Vessal, PhD, senior director of research and operation for the foundation, to advance a paste graft…
Timothy Scannell, former president and COO at Stryker, was added to the board of directors at Collagen Matrix.
Life sciences company BioRestorative Therapies has been named one of the 10 most innovative regenerative medicine companies in 2022 by Insights Care Magazine.